High Resolution Diffusion Weighted Imaging in Prostate
Recruiting · NCT06636747 · Observational (researchers observe without assigning treatment) · Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
View the official record on ClinicalTrials.gov →What this trial is about
hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI
Who can take part
Age range
55 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
- Complete clinical information.
Exclusion criteria
- Men were excluded if they were using 5-alpha-reductase inhibitors at time of examination or has used such during the previous six months; or if they had a previous history of prostatic biopsy, prostatic surgery, or treatment for PCa
Where it is running
2 locations listed.
- Yu-Dong Zhang - Nanjing, China
- The First Affiliated Hospital with Nanjing Medical University - Nanjing, Jiangsu, China